In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
Using microbubbles and ultrasound, researchers have created a cancer treatment that kills tumor cells and recruits immune cells to the tumor.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
Teens and young adults with cancer face biological and psychosocial challenges distinct from those of other cancer patients.
Stanford scientists have taken important steps toward figuring out how to use immune therapy for a group of severe pediatric brain tumors.
Stanford researchers are devising new ways to tackle cancer through better, more sophisticated diagnostics and treatments.
A Stanford neurologist and her colleagues are zeroing in on identifying causes and treatments for chemo brain.
Stanford Medicine will be the first to use a new technology that aims to heighten precision of radiation therapy in cancer patients.
In the Stanford Medicine course Walk with Me, students are paired with patients to learn about life with a chronic or serious illness.
Stanford physician Lucy Kalanithi opens up about loss, grief and love for her neurosurgeon husband, Paul, five years after his death from lung cancer.
Learn about chemo brain and what's new in cancer treatment, research and education in Stanford Medicine magazine's new issue highlighting the disease.
Stanford dermatologist Roxana Daneshjou describes the advantages of using Twitter to discuss methods and findings of research papers.
Stanford researchers are working on a test to identify early-stage lung cancer by detecting tumor-specific mutations in bits of DNA in the bloodstream.
Scientists create a new 3D lung cancer model to better reveal the drivers of cancer, and in doing so, find a new gene that may be a possible drug target.
A Stanford oncologist discusses how to improve cancer diagnosis and treatment, including using predictive modeling, liquid biopsies and immunotherapy.
A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells.
